The Story Of Our Firm | En Español
 Home    Lawyers   Litigation   Choose Us   Settlements   Search

Drugs ReNu MoistureLoc Research Center News & Warnings

FDA Warning

in this section: The Danger of Contact Lens Solutions


Bookmark This Page Print This Page Email This Page

FDA Warning - Bausch & Lomb’s ReNu with MoistureLoc May Cause Fusarium Keratitis


BREAKING NEWS: AMO Complete MoisturePlus Multi-Purpose Solution has been recalled by its manufacturer due to an infection that may lead to blindness. To learn more about the recall and the dangers associated with it, click HERE.

ReNu Brand contact lens solution, manufactured by Bausch & Lomb, has caused its users to develop a fungus called fusarium in their eyes after cleaning their lenses with ReNu, which can lead to loss of vision, and blindness.

On April 10th, 2006 the FDA released a warning with regards to ReNu brand contact lens solution.

If you or a loved one has developed any serious side effects after using ReNu contact lens solution, you can file a lawsuit to get compensation for your injuries. Contact Weitz & Luxenberg today by filling out this simple form for a free lawsuit case review within 24 hours.




FDA News

FOR IMMEDIATE RELEASE
P06-56
April 10, 2006

Media Inquiries:
Susan Cruzan, 301-827-6242
Consumer Inquiries:
888-INFO-FDA


Investigation of Serious Eye Infections Associated With Soft Contact Lens Use and Contact Lens Solution
Consumers Are Advised to Follow Good Hygiene Practices and Manufacturers’ Instructions to Prevent Infection

The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are alerting health care professionals and their patients who wear soft contact lenses to an increasing number of reports in the United States of rare but serious fungal infections in the eye that can cause permanent loss of sight. Some patients have reported a significant loss of vision, resulting in the need for a corneal transplant.

A fungus called Fusarium has been identified as the cause of the reported infections. As of April 9, 2006, 109 cases of suspected Fusarium keratitis are under investigation by CDC and public health authorities in 17 states of the U.S.

"This is a serious infection and soft contact lens users should be mindful of the potential to develop this problem," said Dr. Daniel Schultz, director of the FDA's Center for Devices and Radiological Health. "We're advising consumers to practice good basic hygiene and follow manufacturers' instructions for proper use, cleaning and storage of their lenses, and report any signs of infection to their doctors."

Clinicians who evaluate patients with microbial keratitis should consider that a fungal infection may be involved and refer the patient to an ophthalmologist, if appropriate to obtain a specimen for laboratory analysis. In addition, the FDA and CDC are urgently advising consumers to take precautions to prevent contamination of the soft lenses and the products used to maintain them. These preventive practices for contact lens wearers include the following:

  • Wash hands with soap and water, and dry (lint-free method) before handling lenses.
  • Wear and replace lenses according to the schedule prescribed by the doctor.
  • Follow the specific lens cleaning and storage guidelines from the doctor and the solution manufacturer.
  • Keep the contact lens case clean and replace every 3-6 months.
  • Remove the lenses and consult your doctor immediately if you experience symptoms such as redness, pain, tearing, increased light sensitivity, blurry vision, discharge or swelling.

In addition, regardless of which cleaning/disinfecting solution used, wearers may want to consider performing a "rub and rinse" lens cleaning method, rather than a no rub method, in order to minimize the number of germs and reduce the chances of infection.

Of the 30 patient cases fully investigated so far, 28 wore soft contact lenses and two reported no contact lens use. Twenty-six of the soft contact lens users who remembered which solution they used during the month prior to the infection onset reported using a Bausch & Lomb ReNu brand contact lens solution or a generic brand manufactured by the same company. Five case-patients reported using other solutions in addition to the ReNu brand, and 9 patients reported wearing contact lenses overnight, a known risk factor for microbial keratitis.

"It is important to note that some of the affected patients had used other solutions in addition to the ReNu brand, and that the source of this fungus has not yet been identified. But we're working with CDC and Bausch & Lomb -- and we're investigating other possible causes -- to prevent these infections," Dr. Schultz added.

Bausch and Lomb has informed FDA that they are voluntarily stopping shipment of the ReNu Moisture Loc product while they are continuing to investigate the cause of these infections. Soft contact lens users who have existing supplies of the Renu Moisture Loc should use the product with caution and report any signs and symptoms of eye infection to their doctors.

Clusters of Fusarium keratitis were reported among contact lens users in Asia beginning in November 2005. In February 2006, Bausch & Lomb voluntarily suspended sales of its ReNu multipurpose solutions in Singapore and Hong Kong after multiple reports of the infection among contact lens users there. No other jurisdictions have taken similar action to date.

Fusarium species are normally found in many plants, soil, and tap water. The annual risk of contact lens-related microbial keratitis is estimated in most studies to be between four and 21 per 10,000 patients, depending on whether the lenses are worn only during the day or continuously overnight.

Fungal keratitis can be associated with trauma to the surface of the eye, immunodeficiencies, and contact lens use. Organisms associated with contact lens-related keratitis are usually bacteria rather than fungus, often arising from contamination of lens care products or from contact lens storage cases.

Additional information is available on FDA's website:

Public Health Notice: www.fda.gov/cdrh/safety/041006-keratitis.html

Centers for Disease Control MMWR: www.cdc.gov/mmwr/

####

Click To Talk To Us Online

Please complete the following questionnaire:

How long have you worn contact lenses?
How long have you been using ReNu with MoistureLoc contact lens solution?
Have you developed: fungal eye infection
any loss of vision
Were you using ReNu with MoistureLoc in the month prior to your eye infection?Yes
No
Have you sought treatment from a physician for your symptoms?Yes
No
Have you had a corneal transplant?Yes
No
Have you been told by a Doctor that you may need a corneal transplant?Yes
No
If yes to any of the above, please describe:
Additional Comments/Questions
Name
Email
Phone Number


see also:

The Danger of Contact Lens Solutions AMO and ReNu, Acanthamoeba and Fusarium: What brings it all together?
Have you contracted acanthamoeba or fusarium from ReNu or AMO?

Bausch & Lomb Press Release Bausch & Lomb Press Release: ReNu MoistureLoc
Bausch & Lomb's Press Release about ReNu MoistureLoc and eye infection

News & Warnings ReNu Lawsuit - Bausch & Lomb’s Contact Lens Solution News & Warnings
Keep up to date with ReNu Brand contact lens solution News & Warnings


Name Phone Email
Do you have a legal question? Ask us!   strictly confidential
Your Question

Click here
for a free case review



$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims

$25 million jury verdict — brake reliner

$5.8 million settlement — failure to perform timely C-Section

$30 million verdict — 7 former power-plant workers suffering from asbestos-related illnesses

$6 million settlement — pediatric malpractice case

$14 million consolidated verdict — 5 asbestos-related cancer suits: shipyards/powerhouses/construction

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$3.5 million — 2 asbestos exposure cases

$600,000 settlement — motor vehicle negligence resulting in serious injury

$44 million verdict — 5 asbestos cases, including $11.6 million awarded to widow of sheet metal worker who died of mesothelioma

$1.6 million settlement — suicide after premature hospital discharge

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$1.5 million settlement — construction worker fell off elevated train tracks

$750,000 settlement — defective construction equipment resulted in serious injury to worker



Ask a Free Question:
Were you injured?

check for your response [login]
For legal help anywhere in the U.S.
A nationally-recognized personal injury law firm, Weitz & Luxenberg is committed to helping clients win cases, get the compensation to which they’re entitled and continue with their lives. In just over 20 years, we’ve collected more than $1.3 billion for plaintiffs.